Abstract:H3K27-wildtype spinal cord gliomas (H3WT-SCGs) are rare and heterogeneous tumors that present significant challenges in pathological classification. Traditional histologic diagnoses often do not align well with the underlying molecular characteristics of these tumors. We characterized 55 cases of H3WT-SCGs using a comprehensive approach that included DNA methylation array, whole-exome sequencing, transcriptome sequencing, proteomics, and single-cell RNA sequencing. Unsupervised clustering analysis was performed to identify distinct molecular subtypes. The analysis identified seven distinct spinal cord methylation (SCM) clusters: pilocytic astrocytomas (PA-SPINE), PA-immune enriched (PA-IME), diffuse leptomeningeal glioneuronal tumor (DLGNT), subependymoma (SUBEPN-SPINE), glioblastoma-like (GBM-like), and pleomorphic xanthoastrocytoma-like (PXA-like). There was a 61.8% discordance between SCM classes and traditional histologic diagnoses. The new molecular classification provided a better correlation with molecular features and patient prognosis. BRAF fusions were enriched in PA-SPINE and DLGNT (p = 0.04), and DLGNT showed significant chromosomal alterations, including 1p loss (p = 6.5e-08) and 1q gain (p = 3.6e-05). Notably, we identified two distinct classes of PA-SPINE: adult (older than 18 years) and pediatric. Adult PAs exhibited lower frequencies of BRAF fusions (p = 1.4e-03), shorter tumor lengths (p = 3.7e-04), and longer progression-free survival (p = 0.062). Adult PA neoplastic cells were less differentiated, with higher expression of EGFR and neuronal markers, and lower cytokine and chemokine expression compared to pediatric cases. Single-cell analysis revealed reduced infiltration of monocyte-derived macrophages and proliferative myeloid cells in adult cases. Both PA-IME and PA-pediatric clusters were characterized as immune-hot tumors with high immune cell enrichment. This study defined clinically relevant molecular classes of H3WT-SCGs that better reflect patient prognosis and molecular characteristics compared to traditional histologic diagnoses. The findings suggest potential therapeutic implications, especially in immune-hot tumors like IME and PA-pediatric, which could benefit from targeted immunotherapies.

Identification of Differentially Expressed Genes and Fusion Genes Associated with Malignant Progression of Spinal Cord Gliomas by Transcriptome Analysis

Identification of Differential Splicing Genes in Gliomas Using Exon Expression Profiling.

Screening Critical Genes Associated with Malignant Glioma Using Bioinformatics Analysis

Analysis of gene expression profiles associated with glioma progression.

Identification of Novel Human Glioblastoma-Specific Transcripts by Serial Analysis of Gene Expression Data Mining

Analysis of Differentially Expressed Genes Based on Microarray Data of Glioma.

Screening of differentially expressed genes associated with human glioblastoma and functional analysis using a DNA microarray.

[Establishment of Malignant Progression Associated Gene Expression Profiles in Human Brain Glioma].

Gene Expression Profiling of Glioblastoma to Recognize Potential Biomarker Candidates

Identification of differentially expressed genes regulated by transcription factors in glioblastomas by bioinformatics analysis.

Genome-wide Expression Profiling of Glioblastoma Using a Large Combined Cohort.

GENE EXPRESSION PROFILING OF GANGLIOGLIOMA MALIGNANT PROGRESSION BY Cdna ARRAY

Gene Expression Meta-Analysis in Diffuse Low-Grade Glioma and the Corresponding Histological Subtypes

A combination of RNA-Seq and CHIP-Seq analysis for determining super enhancer- associated genes to evaluate prognosis and immunity of glioma

Research on Related Molecules of Differentiation and Malignant Progession of Glioma Cells

Integrated Mrnaseq and Micrornaseq Data Analysis for Grade III Gliomas

Integrative Genomic and Transcriptomic Analysis of Primary Malignant Gliomas Revealed Different Patterns Between Grades and Somatic Mutations Related to Glioblastoma Prognosis

Identification of Differentially Expressed Key Genes Between Glioblastoma and Low-Grade Glioma by Bioinformatics Analysis.

Identification of Immune Cell Infiltration and Immune-Related Genes in the Tumor Microenvironment of Glioblastomas

Bioinformatic Analysis of Glioma Development Relative Genes

Path-17. Molecular Classification Of H3K27-Wildtype Spinal Cord Gliomas: Implications For Prognosis And Therapeutics